APRE vs AAPL · $10.4M cap vs P/E 39, rev $416.16B
Aprea Therapeutics Inc (APRE) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
APRE does not have a complete income-statement cache yet.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
APRE currently screens at market cap $10.4M. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Not investment advice. Open the APRE and AAPL stock pages for the full models.
Not investment advice.